Published in AIDS Weekly, March 6th, 1995
Mycobutin is the only drug available in the United States for the prevention of disseminated Mycobacterium avium complex (MAC), the fastest growing bacterial opportunistic infection (0I) in people with HIV. By the year 2000, 90 million new cases of TB and 30 million deaths are expected worldwide, according to a recent report in the Journal of the American Medical Association, the company noted.
The major study is an international, multicenter clinical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.